A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
Kai Zhao(Qingdao University), Tillmann Rusch(Goethe University Frankfurt)
Cited by 4
Related Papers
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner
|Cell Death and Disease|2019|73
Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
|Scientific Reports|2016|61
Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
|International Journal of Molecular Sciences|2021|30
Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2 /neu or EpCAM as target receptors
|Molecular Therapy — Oncolytics|2016|22